Language: BG BG
← Back to results
Recruiting Phase 1 NCT05962424

HNC: Human Neural Circuits Electrophysiology During Cognition

Phase 1 – testing safety in a small group of people
Conditions: Psychiatric Disorder

Sponsor: Stanford University

trial.available_in: БГ
Overview
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Description
The goal of this proposed research is to record the effects of ketamine on brain activity to understand the changes that occur during antidepressant therapy and the side effect of dissociation. This research is designed to probe altered cognitive states associated with dissociation, depression, and other neuropsychiatric conditions.
Who can participate
Inclusion Criteria: * Patient in clinical neuro inpatient units at Stanford Medical Center * Age \>18 years old * Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex) Exclusion Criteria: * Lifetime psychotic disorder * Pregnant or nursing females * Prior adverse ketamine response * Use of ketamine in past 7 days
Interventions
Ketamine Hydrochloride
DRUG
Locations 1
United States (1)
Stanford University
Palo Alto , California
Technical details
Status
Recruiting
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
05.10.2023
Completion date
01.09.2030
Registry ID
NCT05962424
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.